Novena Global Lifecare gets US$20m in funding, joins US$150m investment fund with partners

SINGAPORE'S Novena Global Healthcare has bagged US$20 million in investment from Sinopharm Capital and Cedarlake Capital Group.

The US$20 million investment will be used to grow the Singapore aesthetic healthcare firm's existing business in China and South-east Asia. This is while leveraging on Sinopharm Capital’s network and resources for its China expansion. Nelson Loh, executive chairman and co-founder of DORR Group and Novena Global Lifecare, said the company will continue to innovate and disrupt the lifecare industry around the region.

대한민국 최근 뉴스, 대한민국 헤드 라인